Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection

dc.creatorValdivieso, Francisca
dc.creatorVial, Pablo
dc.creatorFerres, Marcela
dc.creatorYe, Chunyan
dc.creatorGoade, Diane
dc.creatorCuiza, Analía
dc.creatorHjelle, Brian
dc.date.accessioned2015-01-13T13:22:54Z
dc.date.accessioned2022-10-17T17:56:34Z
dc.date.available2015-01-13T13:22:54Z
dc.date.available2022-10-17T17:56:34Z
dc.date.created2015-01-13T13:22:54Z
dc.date.issued2006
dc.identifierEmerging Infectious Diseases, January 2006, vol. 12, n°. 1, p. 166-168
dc.identifierhttp://dx.doi.org/10.3201/eid1201.050930
dc.identifierhttp://hdl.handle.net/11447/45
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4425052
dc.description.abstractWe evaluated titers of homotypic and heterotypic neutralizing antibodies (NAbs) to Andes and Sin Nombre hantaviruses in plasma samples from 20 patients from Chile and the United States. All but 1 patient had high titers of NAb. None of the plasma samples showed high titers against the heterologous virus.
dc.languageen_US
dc.publisherCenters for Disease Control and Prevention
dc.subjectHantavirus
dc.subjectAndes virus
dc.subjectNeutralizing antibodies
dc.subjectSin Nombre virus
dc.titleNeutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection
dc.typeArtículo


Este ítem pertenece a la siguiente institución